Recombinant BNP on Heart and Renal Function in Acute Heart Failure

• Status: Unknown status
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety of recombinant human B-type natriuretic peptide (rhBNP) on heart and renal function in patients with acute decompensated heart failure (ADHF) and acute renal injury (AKI).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai Chest Hospital

Criteria

Inclusion Criteria:

• acute heart failure with acute renal injury

Exclusion Criteria:

• not tolerate to rhBNP